British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017

Autor:	Ian Jones, Angelika Wieck, E McDonald, NC Smith, RH McAllister-Williams, Nadia Micali, L Green, David Taylor, A Roberts, Abigail Easter, A Gregoire, Carmine M. Pariante, R Cantwell, L Peters, A. H. Young, Laura Yates, Eilish Gilvarry, Louise M. Howard, Glover, Anne Lingford-Hughes, David S. Baldwin, Hind Khalifeh
Přispěvatelé:	Genesis Research Trust
Jazyk:	angličtina
Rok vydání:	2017
Předmět:	TRANSCRANIAL MAGNETIC STIMULATION breastfeeding Psychopharmacology Psychopharmacology/standards POPULATION-BASED COHORT Breastfeeding hypnotics 0302 clinical medicine Pregnancy PRENATAL ANTIDEPRESSANT EXPOSURE Childbirth Pharmacology (medical) Pharmacology & Pharmacy postpartum media_common Psychiatry fertility Mental Disorders Postpartum Period mood stabilisers Antidepressants 11 Medical And Health Sciences SEROTONIN-REUPTAKE INHIBITORS Psychiatry and Mental health Autism spectrum disorder Female Life Sciences & Biomedicine anxiolytics medicine.medical_specialty DEFICIT HYPERACTIVITY DISORDER media_common.quotation_subject Clinical Neurology Fertility Breast milk Postpartum Period/drug effects Psychotropic Drugs/therapeutic use BENZODIAZEPINE-RECEPTOR AGONISTS 17 Psychology And Cognitive Sciences 03 medical and health sciences medicine INTRAUTERINE GROWTH-RETARDATION Humans child development Pharmacology Psychotropic Drugs Science & Technology pregnancy outcome psychotropics business.industry AUTISM SPECTRUM DISORDER Neurosciences medicine.disease Mental Disorders/drug therapy Mental health Child development PERSISTENT PULMONARY-HYPERTENSION 030227 psychiatry antipsychotics birth defects psychiatric illness Neurosciences & Neurology IN-UTERO EXPOSURE Antidepressants antipsychotics anxiolytics birth defects breastfeeding child development conception fertility hypnotics mood stabilisers neonatal problems postpartum pregnancy pregnancy outcome psychiatric illness psychotropics teratogenicity conception teratogenicity business neonatal problems 030217 neurology & neurosurgery
Zdroj:	McAllister-William, R H, Baldwin, D S, Cantwell, R, Easter, A, Gilvarry, E, Glover, V, Green, L, Gregoire, A, Howard, LM, Jones, I, Khalifeh, H, Lingford-Hughes, A, McDonald, E, Micali, N, Pariante, C, Peters, L, Robert, A, Smit, N, Taylor, D, Wieck, A, Yates, L M & Young, A H 2017, ' British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017 ', Journal of Psychopharmacology, vol. 31, no. 5, pp. 519-552 . https://doi.org/10.1177/0269881117699361 Journal of Psychopharmacology, Vol. 31, No 5 (2017) pp. 519-552
ISSN:	0269-8811
DOI:	10.1177/0269881117699361
Popis:	Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge for clinicians and women with mental health problems, owing to the uncertainties around risks of the illness itself to mother and fetus/infant, effectiveness of medications in pregnancy and risks to the fetus/infant from in utero exposure or via breast milk. These consensus guidelines aim to provide pragmatic advice regarding these issues. They are divided into sections on risks of untreated illness in pregnancy; general principles of using drugs in the perinatal period; benefits and harms associated with individual drugs; and recommendations for the management of specific disorders.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa84a1c021e73d1f45598b476bb6d358 https://eprints.soton.ac.uk/412409/ Zobrazit plný text záznamu